0000899243-22-014963.txt : 20220418 0000899243-22-014963.hdr.sgml : 20220418 20220418161514 ACCESSION NUMBER: 0000899243-22-014963 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220414 FILED AS OF DATE: 20220418 DATE AS OF CHANGE: 20220418 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Apeiron Investment Group Ltd. CENTRAL INDEX KEY: 0001845711 STATE OF INCORPORATION: O1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40493 FILM NUMBER: 22832309 BUSINESS ADDRESS: STREET 1: BLOCK A, APT.12 STREET 2: IL-PIAZZETTA, TOWER ROAD CITY: SLIEMA STATE: O1 ZIP: SLM1605 BUSINESS PHONE: 44 7557 251 563 MAIL ADDRESS: STREET 1: BLOCK A, APT.12 STREET 2: IL-PIAZZETTA, TOWER ROAD CITY: SLIEMA STATE: O1 ZIP: SLM1605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Angermayer Christian CENTRAL INDEX KEY: 0001845872 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40493 FILM NUMBER: 22832308 MAIL ADDRESS: STREET 1: BLOCK A, APT.12 STREET 2: IL-PIAZZETTA, TOWER ROAD CITY: SLIEMA STATE: O1 ZIP: SLM1605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATAI Life Sciences N.V. CENTRAL INDEX KEY: 0001840904 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 180 VARICK STREET CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: (617) 699-5876 MAIL ADDRESS: STREET 1: 180 VARICK STREET CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: ATAI Life Sciences B.V. DATE OF NAME CHANGE: 20210115 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-04-14 0 0001840904 ATAI Life Sciences N.V. ATAI 0001845711 Apeiron Investment Group Ltd. 66 & 67, BEATRICE, AMERY STREET SLIEMA O1 SLM1707 MALTA 0 0 1 0 0001845872 Angermayer Christian 66 & 67, BEATRICE, AMERY STREET SLIEMA O1 SLM1707 MALTA 0 0 1 0 Common Shares 2022-04-14 4 P 0 4967 5.19 A 1358883 I By Apeiron Presight Capital Fund II, L.P. The price reported in Column 4 is a weighted average price. The common shares were purchased in multiple transactions at prices ranging from $5.13 to $5.20 per share. The reporting persons undertake to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Apeiron Investment Group Ltd. By: /s/ Julien Hofer, Director 2022-04-18 /s/ Christian Angermayer 2022-04-18